Pyrazole derivatives as psychopharmaceuticals
CA 2467081 A1 · Owner: Merck Patent Gesellschaft Mit Beschraenkter Haftung · Inventors: Seyfried, Christoph; Boettcher, Henning; Bartoszyk, Gerd
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to pyrazole derivatives of Formula (I) in which R1, X, Z and n have the meanings indicated above their preparation and their use as , psychopharmaceuticals and/or as active compounds of medicaments for the treatment and prophylaxis of movement disorders and/or for the manufacture of a medicament for the treatment of adverse effects of anti-Parkinsonian drugs in extrapyramidal movement disorders and/or for the manufacture of a medicament for the treatment of extrapyramidal symptoms (EPS) induced by neuroleptics.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 14, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 14, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 14, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.